Radiotherapy in Combination with CD20×CD3 Bispecific Antibodies for B-Cell Lymphoma: Biological Rationale, Current Evidence, and Open Questions. (PubMed, Cancers (Basel)) - Sep 16, 2026 - "It does not establish the benefit, synergy, or optimal sequencing. Prospective studies are needed to define the role of RT in this setting."
Journal • Review • B Cell Lymphoma • B Cell Non-Hodgkin Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • CD20
|
|
Alberto Bavieri; Emanuele Alì; Maria Elena Nizzoli; Patrizia Ciammella
|